HMVUX | JVMCX | HMVUX / JVMCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 14 years | - |
Gain YTD | 0.127 | 2.016 | 6% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.16B | 22.5B | 5% |
Annual Yield % from dividends | 0.89 | 0.01 | 6,252% |
Returns for 1 year | -2.75 | -5.08 | 54% |
Returns for 3 years | N/A | 1.19 | - |
Returns for 5 years | N/A | 30.64 | - |
Returns for 10 years | N/A | 28.24 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RIGS | 23.17 | -0.07 | -0.28% |
RiverFront Strategic Income ETF | |||
GMET | 20.72 | -0.09 | -0.43% |
VanEck Green Metals ETF | |||
HNDL | 21.59 | -0.14 | -0.64% |
Strategy Shares Nasdaq 7 Handl™ ETF | |||
PBE | 65.49 | -1.22 | -1.83% |
Invesco Biotechnology & Genome ETF | |||
IGM | 97.24 | -2.85 | -2.85% |
iShares Expanded Tech Sector ETF |